Haciendo equilibrios entre los riesgos y beneficios del tratamiento farmacológico en demencia, dolor crónico y anticoagulación en personas mayores

Domínguez, Maria José Fernández; Gómez, María Lorena; Barral, Araceli Garrido; Moneo, María Jesús González

doi:10.1016/j.aprim.2018.09.003

Cited by 8 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There are various drugs indicated for dementia (cholinesterase inhibitors and memantine) and others to treat psychological and behavioral symptoms associated with dementia (neuroleptics, antidepressants, analgesics, etc. ), all of which have side effects [5]. There are several studies that relate comorbidity and polypharmacy in people with dementia [6].…”

Section: Introductionmentioning

confidence: 99%

Benefits of Dog-Assisted Therapy in Patients with Dementia Residing in Aged Care Centers in Spain

Parra

Garre

Pérez

2021

IJERPH

View full text Add to dashboard Cite

(1) Background: Currently, the scientific evidence on the benefits of assisted therapy with dogs in dementia is not clear. In this study, we want to evaluate such benefits through a randomized controlled clinical trial in multiple centers across the country. (2) Methods: The participants were people over 65 years old with dementia, residing in senior centers in Spain (n = 334). The experimental group underwent assisted therapy with dogs based on the Comprehensive Cognitive Activation Program in Dementia, for 8 months, with weekly sessions of 45 min. Data were collected at the commencement, middle, and end of the program, to evaluate the aspects using the Mini-Examination Cognitive, the modified Bartell Index, the Cornell Scale for Depression in Dementia and the Neuropsychiatric Inventory. (3) Results: The results show significant improvements in the experimental group versus the control group in the affective (T1 = p 0.000; T2 = p 0.000) and behavioral (T1 = p 0.005; T2 = p 0.000) aspects, with the affective aspect displaying greater progress in participants with additional depressive (p = 0.022) or anxiety (p = 0.000) disorders, shorter institutionalization periods (r = −0.222, p = 0.004), and those undergoing complementary psychotherapy (p = 0.033) or alternative therapy (p = 0.011). (4) Conclusions: Dog therapy is effective in improving the affective and behavioral aspects of institutionalized patients with dementia.

show abstract

Section: Introductionmentioning

confidence: 99%

Benefits of Dog-Assisted Therapy in Patients with Dementia Residing in Aged Care Centers in Spain

Parra

Garre

Pérez

2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…Given the complex nature of chronic pain, its appropriate treatment often requires individualized assessments by multidisciplinary teams capable of addressing the physical and psychological aspects of pain [ 4 , 5 ]. It also requires pharmacological treatment, which is a common component of chronic pain management regimens [ 6 , 7 ]. Such treatment often includes the use of nonopioid and opioid analgesics, as well as adjuvant medications used to prevent or treat the adverse effects of analgesics or enhance the effect of opioid analgesics.…”

Section: Introductionmentioning

confidence: 99%

Predictive variables of prescription opioid misuse in patients with chronic noncancer pain. Development of a risk detection scale: A registered report protocol

2021

View full text Add to dashboard Cite

Background Opioid therapy is utilized for a broad range of chronic pain conditions. Several studies have highlighted the adverse effects of opioid medication due to the misuse of these drugs. The gradual increase in the use of opioids has become a global phenomenon and is generating social concern. Several treatment guidelines have strongly recommended assessing the risks and benefits of pharmacological treatment with opioids. These guidelines also recommend the psychological assessment of patients with chronic noncancer pain in order to make informed decisions on the advisability of intervention with opioids. Some authors have emphasized the relevance of assessing the risk of opioid misuse in patients with noncancer chronic pain before initiating treatment. Methods and analysis Two studies will be conducted, each with a different primary objective. The primary objective of the first study (Study 1) will be to conduct a comprehensive investigation to identify the factors most closely associated with subsequent opioid misuse; and based on the results of Study 1, the primary objective of the second study (Study 2) will be to develop a brief, reliable, valid, and useful instrument that would enable health care providers to make decisions on opioid prescription and on the required level of monitoring and follow-up. These decisions would have positive consequences for patient wellbeing. Study 1 will include a logistic regression analysis to test the hypothetical model. Study 2 will have a longitudinal design and include three assessment sessions in order to develop a measure to assess the risk of prescribed opioid misuse and to analyse its reliability and validity. Participants will be individuals with chronic noncancer pain attending three Pain Units. These individuals will either be undergoing pharmacological treatment that includes opioid analgesics (Study 1, N = 400) or are going to commence such treatment (Study 2, N = 250).

show abstract

“…Como se expone en el artículo «Haciendo equilibrios entre los riesgos y beneficios del tratamiento farmacológico en demencia, dolor crónico y anticoagulación en personas mayores» 1 no hay estudios específicos de la efectividad de los tratamientos en dolor crónico no oncológico (DCNO) en ancianos. A falta de ellos lo más práctico sería asimilarlos a la población general, considerando sus particularidades.…”

unclassified

Mitos y realidades en torno al tratamiento del dolor crónico no oncológico. ¿Son los ancianos diferentes?

Espinosa¹,

Checa²

2019

Atención Primaria

View full text Add to dashboard Cite

Haciendo equilibrios entre los riesgos y beneficios del tratamiento farmacológico en demencia, dolor crónico y anticoagulación en personas mayores

Cited by 8 publications

References 18 publications

Benefits of Dog-Assisted Therapy in Patients with Dementia Residing in Aged Care Centers in Spain

Benefits of Dog-Assisted Therapy in Patients with Dementia Residing in Aged Care Centers in Spain

Predictive variables of prescription opioid misuse in patients with chronic noncancer pain. Development of a risk detection scale: A registered report protocol

Mitos y realidades en torno al tratamiento del dolor crónico no oncológico. ¿Son los ancianos diferentes?

Contact Info

Product

Resources

About